Validea’s guru fundamental report for MERCK & CO INC (MRK) shows that it rates highest using the P/E/Growth Investor model based on Peter Lynch’s strategy. MRK is a large-cap value stock in the Biotechnology & Drugs industry, with a 93% rating based on fundamentals and valuation. The stock meets most of the criteria in Lynch’s strategy, such as P/E ratio, sales, EPS growth rate, and debt/equity ratio. Peter Lynch is known for his common sense approach to investing and his success at Fidelity’s Magellan Fund. Validea offers investment research services based on strategies of investment legends like Lynch.

Read more at Nasdaq: MRK Factor-Based Stock Analysis – Peter Lynch